Bo Chen, MD

Bo Chen is associate chief physician and associate professor of medicine at Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China. He obtained his Bachelor Degree of Medicine from Bethune Medical University in 2002, and his Master Degree and Doctor Degree of Oncology from Peking Union Medical College in 2007 and 2014.

He has engaged in radiation oncology from 2002. He is majored in treatment and research of radiotherapy for liver cancer, breast cancer, rectal cancer, lymphoma, prostate cancer, gastric cancer and other abdominal tumors. Especially, he devoted many years of his career studying the radiotherapy and prognosis of liver cancer. His team treated 150-200 patients of liver cancer by radiotherapy per year. Currently, he leads 6 clinical trials of radiotherapy of liver cancer completed and ongoing, such as phase II study of adjuvant radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma (ClinicalTrials.gov NCT01456156, completed, published in Hepatology), phase II study of concurrent sorafenib and radiotherapy for advanced hepatocellular carcinoma with portal vein and/or hepatic vein tumor thrombosis (ClinicalTrials.gov NCT03535259, completed, this study), phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT (ClinicalTrials.gov NCT04791176, ongoing), and so on. He has published more than 30 articles in peer-reviewed journals, and 3 chapters of books. He has received competitive funding for more than 6 projects, include the National Key Projects of Research and Development of China.

Disclosures: